Reza Gamagami, MD
Surgery · New Lenox, ILNPI 1275517153
Payments from drug & device makers
Across 1,499 payments — averaging $830.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$1.2M
- Intuitive Surgical Operations, Inc.$59K
- W. L. Gore & Associates, Inc.$12K
- Davol Inc.$6K
- Covidien LP$2K
- Baxter Healthcare$2K
- plus $4K from 32 others
What the payments were for
- Consulting fees$29,5102%
- Speaking & faculty fees$135,75011%
- Grants$1,0000%
- Travel & lodging$92,2068%
- Food & beverage$21,6152%
- Education$905,99476%
- Gifts$3330%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 1,316 | $1,158,833 |
| Intuitive Surgical Operations, Inc. | 3 | $58,600 |
| W. L. Gore & Associates, Inc. | 20 | $12,425 |
| Davol Inc. | 18 | $6,416 |
| Covidien LP | 4 | $2,361 |
| Baxter Healthcare | 2 | $2,130 |
| Cook Medical LLC | 1 | $1,000 |
| Johnson & Johnson | 10 | $584 |
| Nestle Healthcare Nutrition Inc. | 33 | $386 |
| AbbVie | 18 | $326 |
| Medtronic(2 entities) | 8 | $265 |
| Merck | 8 | $187 |
| BD | 4 | $181 |
| Braintree Laboratories, Inc. | 7 | $165 |
| Aimmune Therapeutics, Inc. | 13 | $151 |
| Endogastric Solutions, Inc | 2 | $148 |
| TELA Bio, Inc. | 3 | $123 |
| KCI USA, Inc. | 1 | $73 |
| Histosonics, Inc. | 1 | $69 |
| Conmed Corporation | 2 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $52 |
| Smith+Nephew | 3 | $50 |
| Vertex | 2 | $48 |
| Pacira Pharmaceuticals Incorporated | 2 | $48 |
| Integra Lifesciences Corporation | 2 | $45 |
| Heron Therapeutics, Inc. | 2 | $45 |
| Ambu Inc. | 1 | $33 |
| Dilon Technologies, Inc. | 1 | $29 |
| QOL Medical, LLC | 1 | $25 |
| Innocoll Pharmaceuticals Limited | 1 | $24 |
| Polynovo North America LLC | 1 | $24 |
| Sirius Medical Systems | 1 | $22 |
| Coopersurgical, Inc. | 1 | $17 |
| Baudax Bio Inc. | 1 | $15 |
| Exact Sciences | 1 | $15 |
| Osiris Therapeutics Inc. | 1 | $14 |
| TEI Biosciences Inc | 1 | $13 |
| Monaghan Medical Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,123,125
- DA VINCI SP$24,250
- SEAMGUARD Bioabsorbable Staple Line Reinforcement$6,270
- SYNECOR Biomaterial$3,885
- PHASIX$2,500
- ProGrip$2,250
- Non-Franchise (NOF) - NonProduct$2,100
- Phasix Mesh$1,223
- GORE BIO-A Tissue Reinforcement$577
- BIO-A Hernia Plug$303
- BIO-A Tissue Reinforcement$299
- GORE ENFORM Biomaterial$293
- Bard 3DMax Mesh$148
- BD MAX$125
- LINX Reflux Management System$123
- ESOPHYX$118
How this compares
$1,245,008 in reported general payments places this provider in the 95th percentile of 1,180 surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 34 | $63,906 |
| ZenpepLipase/Protease/Amylase | 11 | $27,915 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 57 | $8,989 |
| CholestyramineCholestyramine (With Sugar) | 30 | $1,253 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 54 | $789 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 30 | $435 |
| Famotidine | 28 | $268 |
| Pantoprazole Sodium | 20 | $250 |
| Sucralfate | 18 | $231 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon | $326 | $63,90634 claims |
| Aimmune Therapeutics, Inc.Zenpep | $151 | $27,91511 claims |
| Braintree Laboratories, Inc.Sutab | $165 | $8,98957 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,180 surgery providers in Illinois.
Other surgery in New Lenox
- Erik BorncampNew Lenox$422K
- Laura RagauskaiteNew Lenox$61K
- Luis FernandezMaywood$1.8M
- Jaishankar RamanBurr Ridge$1.6M
- Francesco BiancoChicago$1.2M
- Mark KeldahlChicago$765K
- Michael UjikiEvanston$749K
- Barry RosenBarrington$443K
- Douglas JonesChampaign$425K
- Rami LutfiChicago$411K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.